In contrast, the low and high BSA-adjusted pirfenidone groups showed a decreasing trend in FVC change compared with the control group, although the difference was not statistically significant (p = 0.051).
← all excerpts
Efficacy of low dose pirfenidone in idiopathic pulmonary fibrosis: real world experience from a tertiary university hospital.
1
—
—